Award

Delivery Order #SPE2DR26FF4FB

Delivery Order for Novolog FlexPen by AmerisourceBergen under Pharmaceutical IDV

Buyer

Defense Logistics Agency

Award Amount

$1,072.32

Ceiling

$1,072.32

Awarded

February 11, 2026

Period of Performance

Feb 11, 2026 – Feb 12, 2026

Identifier

SPE2DR26FF4FB

NAICS

424210

This award represents a delivery order contract for the procurement of Novolog 100 Unit/mL FlexPen 3mL insulin units, issued under a larger indefinite delivery vehicle (IDV) contract focused on pharmaceutical supplies. The recipient, AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, is tasked with supplying this critical diabetes medication to support healthcare providers. The contract underscores the agency's ongoing commitment to ensuring timely access to essential pharmaceuticals, vital for public health management. The scope covers the delivery of specified insulin units within a concise performance period, reflecting a targeted fulfillment of medical product needs. This order is a continuation of the substantial multi-year IDV contract with AmerisourceBergen, which strategically supports the agency's pharmaceutical distribution infrastructure. Awarded on a competitive basis as part of the broader IDV vehicle, this action highlights the efficiency and reliability of AmerisourceBergen in fulfilling pharmaceutical procurement requirements. The performance timeframe is a short-term, precise delivery window, ensuring rapid availability of the product at the specified location in Conshohocken, Pennsylvania.

Description

4570802932!NOVOLOG 100 UNIT/ML FLEXPEN 3ML

View original record